参考文献/References:
1 Rubens RD.Bone metastases-incidence and complications.In Rubens RD,Mundy GR.Cancer and the skeleton.London:Martin Dunitz,2000.33-42.
2 Schirrmeister H,Buck A,Guhlmann A,et al.Anatomical distribution and sclerotic activity of bone metastases from thyroid cancer assessed with F-18 sodiumfluoride PET..Thyroid,2001,11(7):677-683.
3 Schirrmeister H,Guhlmann A,Elsner K,et al.Sensitivity in detecting osseous lesions depends on anatomic localization:planar bone scintigraphy versus 18F PET.J Nucl Med,1999,40(10):1623-1629.
4 Hetzel M,Arslandemir C,Konig HH,et al.F-18 NaF PET for detection of bone metastases in lung cancer:accuracy,costeffectiveness and impact on patient management.J Bone Miner Res,2003,18(12):2206-2214.
5 Schirrmeister H,Glatting G,Hetzel J,et al.Prospective evaluation of the clinical value ofplanar bone scans,SPECT and (18)F-labeled NaF PET in newly diagnosed lung cancer.J Nucl Med,2001,42(12):1800-1804.
6 Schirrmeisier H,Buck AK,Bergmann L,et al.PET for staging of solitary plasmacytoma.Cancer Biother Radiopharm,2003,18(5):841-845.
7 Wu HC,Yen RF,Shen YY,et al.Comparing whole body 18F-2-deoxyglucose PET and 99mTc MDP bone scan to detect bone metastases in patients with renal cell carcinomas-a preliminary report.J Cancer Res Clin Oncol,2002,128(9):503-506.
8 Marom EM,McAdams HP,Erasmus JJ,et al.Staging non-small cell lung cancer with whole-body PET.Radiology,1999,212(3):803-809.
9 Cook GJ,Houston S,Rubens R,et al.Detection of bone metastases in breast cancer by 18F-FDG PET:differing metabolic activity in osteoblastic and osteolytic lesions.J Clin Oncol,1998,16(10):3375-3379.
10 Franzius C,Sciuk J,Daldrup-Link HE,et al.FDG PET for detection of osseous metastases from malignant primary bone tumours:comparison with bone scintigraphy.Eur J Nucl Med,2000,27(9):1305-1311.
11 Gallowitsch H J,Kresnik E,Gasser J,et al.F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma:A comparison to conventional imaging.Invest Radiol,2003,38(5):250-256.
12 Jadvar H,Pinski JK,Conti PS.FDG PET in suspected recurrent and metastatic prostate cancer.Oncol Rep,2003,10(5):1485-1488.
13 Gayed I,Vu T,Johnson M,et al.Comparison of bone and 2-dooxy-2-[18F]fluoro-D-glucose PET in the evaluation of bony metastases inlung cancer.Mol Imaging Biol,2003,5(1):26-31.
14 Bury T,Barreto A,Daenen F,et al.Fluorine-18 deoxyglucose positron emission tomography for the detection of bone metastases in patients with non-small cell lung cancer.Eur J Nucl Med,1998,25(9):1244-1247.
15 Stafford SE,Gralow JR,Schubert EK,et al.Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy.Acad Radiol,2002,9(8):913-921
16 Fogelman I,Cook G,Israel O,et al.Positron emission tomography and bone metastaese.Semin Nucl Med,2005,35(2):135-142.
17 Israel O,Mor M,Guralnik L,et al.Is 18F-FDG PET/CT useful for imaging and management of patients with suspected occult recurrence of cancer?.J Nucl Med,2004,45(12):2045-2051.
18 Even-Sapir E,Metser U,Flusser G,et al.Assessment of malignant skeletal disease:initial experience with 18F-fluoride PET/CT and comparison between 11C-fluoride PET and 18F-fluoride PET/CT.J Nucl Med,2004,45(2):272-278.
19 Ho-Shon I,Fogelman I.F-18 FDG PET and benign fractures.Clin Nucl Med,2003,28(3):171-175.
相似文献/References:
[1]廖光星,冷志欣,肖国有.前列腺癌骨转移影像诊断方法研究进展[J].国际放射医学核医学杂志,2016,40(6):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
Liao Guangxing,Leng Zhixin,Xiao Guoyou.Progress of imaging in the diagnosis of bone metastases of prostate cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):464.[doi:10.3760/cma.j.issn.1673-4114.2016.06.012]
[2]周文兰,吴湖炳,韩彦江,等.18F-FDG PET/CT对骨骼孤立性高代谢病灶的初步诊断价值[J].国际放射医学核医学杂志,2015,39(1):14.[doi:10.3760/cma.j.issn.1673-4114.2015.01.005]
Zhou Wenlan,Wu Hubing,Han Yanjiang,et al.Preliminary study of 18F-FDG PET/CT in the diagnosis of solitary hypermetabolic lesion of bone[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):14.[doi:10.3760/cma.j.issn.1673-4114.2015.01.005]
[3]张胤,陈跃.18F-氟化钠PET/CT诊断肿瘤骨转移应用进展[J].国际放射医学核医学杂志,2015,39(1):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
Zhang Yin,Chen Yue.Application progress of 18F-NaF PET/CT in the diagnosis of neoplasm metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):96.[doi:10.3760/cma.j.issn.1673-4114.2015.01.020]
[4]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[5]刘雪辉,李洪均,于鸿煦.SPECT/CT融合显像对可疑骨转移灶的诊断效能[J].国际放射医学核医学杂志,2015,39(3):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
Liu Xuehui,Li Hongjun,Yu Hongxu.Diagnostic efficacy of SPECT/CT fusion imaging in assessing possible bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):201.[doi:10.3760/cma.j.issn.1673-4114.2015.03.003]
[6]桂继琮,刘兴党.镭-223氯化物治疗去势抵抗性前列腺癌骨转移的研究进展[J].国际放射医学核医学杂志,2015,39(3):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
Gui Jicong,Liu Xingdang.Development in the study of radium-223 chloride for treating castration-resistant prostate carcinoma with bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):268.[doi:10.3760/cma.j.issn.1673-4114.2015.03.018]
[7]高平,王茜,赵赟赟,等.99Tcm-MDP SPECT/CT显像用于骨肉瘤肺转移的诊断[J].国际放射医学核医学杂志,2014,38(3):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
Gao Ping,Wang Qian,Zhao Yunyun,et al.99Tcm-MDP SPECT/CT used in diagnosis of pulmonary metastasis from osteosarcoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):148.[doi:10.3760/cma.j.issn.1673-4114.2014.03.002]
[8]凌彩霞,肖国有.SPECT/CT骨断层显像及在恶性肿瘤骨转移诊断中的临床价值[J].国际放射医学核医学杂志,2014,38(4):275.[doi:10.3760/cma.j.issn.1673-4114.2014.04.016]
Ling Caixia,Xiao Guoyou.The clinical value of SPECT/CT bone tomography in the diagnosis of malignant tumor metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):275.[doi:10.3760/cma.j.issn.1673-4114.2014.04.016]
[9]王宇峰,刘海娜,张居洋,等.SPECT/CT融合显像对乳腺癌骨转移的诊断价值[J].国际放射医学核医学杂志,2014,38(6):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
Wang Yu-feng,Liu Hai-na,Zhang Ju-yang,et al.Clinical value of SPECT/CT fusion imaging in diagnosing metastatic bone lesions in breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):387.[doi:10.3760/cma.j.issn.1673-4114.2014.06.010]
[10]赵红光,徐松柏,关锋,等.骶骨脊索瘤伴肺转移18F-FDG PET/CT显像一例[J].国际放射医学核医学杂志,2013,37(2):128.[doi:10.3760/cma.j.issn.1673-4114.2013.02.017]
[11]刘超,邓智勇,刘鹏杰,等.89SrCL2与唑来膦酸联合治疗乳腺癌转移性骨肿瘤的疗效分析[J].国际放射医学核医学杂志,2014,38(5):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
Liu Chao,Deng Zhi-yong,Liu Peng-jie,et al.Analysis on the curative effect of combination therapy with zoledronic acid and 89SrCL2 on bone tumor with breast cancer metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(2):300.[doi:10.3760/cma.j.issn.1673-4114.2014.05.006]
[12]袁超,李卫鹏,胡永全,等.89Sr治疗乳腺癌和前列腺癌多发性骨转移的临床观察[J].国际放射医学核医学杂志,2010,34(4):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
YUAN Chao,LI Wei-peng,HU Yong-quan,et al.Clinical observation of 89Sr treatment efficacy of multiple bone metastases in breast and prostate cancer patients[J].International Journal of Radiation Medicine and Nuclear Medicine,2010,34(2):220.[doi:10.3760/cma.j.issn.1673-4114.2010.04.008]
[13]何建华,喻文才.89SrCl2与153Sm-乙二胺四亚甲基膦酸治疗骨转移癌的对比研究[J].国际放射医学核医学杂志,2009,33(2):86.[doi:10.3760/cma.j.issn.1673-4114.2009.02.007]
HE Jian-hua,YU Wen-cai.Comparison of treatment with 89SrCl2 and 153Sm-ethylenediaminetetramethylene phosphate in metastatic cancers of bone[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(2):86.[doi:10.3760/cma.j.issn.1673-4114.2009.02.007]
[14]叶慧,莫逸,谢爱民,等.18F-氟脱氧葡萄糖PET-CT与99nTc-亚甲基二膦酸盐骨显像诊断转移性骨肿瘤的对比研究[J].国际放射医学核医学杂志,2008,32(3):147.
YE Hui,MO Yi,XIE Ai-min,et al.Comparison study of 18F-fluorodeoxyglucose PET-CT and 99Tc-methylene phospho-nate bone scan in detecting bone metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(2):147.
[15]郭睿,晋建华,任媛,等.99mTc-枸橼酸盐显像鉴别骨转移癌与良性退行性骨病变[J].国际放射医学核医学杂志,2008,32(3):162.
GUO Rui,JIN Jian-hua,REN Yuan,et al.Differentiation of malignant and degenerative benign bone disease using 99mTc-citrate scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(2):162.
[16]耿峻,吴兴勇,胡德胜,等.前列腺癌48例患者全身核素骨显像的临床价值[J].国际放射医学核医学杂志,2007,31(4):238.
[17]青春,邓候富,贾志云.放射性核素89Sr治疗骨转移癌的新进展[J].国际放射医学核医学杂志,2007,31(3):160.
QING Chun,DENG Hou-fu,JIA Zhi-yun.The new advances of radionuclide 89Sr in metastatic bone cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2007,31(2):160.